<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jacquelyn M Powers, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven A Abrams, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarah O'Brien, MD, MSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Iron deficiency is the most common nutritional deficiency in children. The global prevalence of anemia in 2010 was 32.9 percent, with the highest burden in children less than five years of age [<a href="#rid1">1</a>]. Iron deficiency is a particularly challenging problem for resource-limited nations in Asia and Africa [<a href="#rid2">2,3</a>]. In the United States and other resource-abundant settings, rates of iron deficiency are substantially lower, yet iron deficiency is still common and can have important consequences to health and development.</p><p>This topic review focuses on evaluation for anemia that is likely due to iron deficiency in infants and young children, including screening, clinical manifestations, and diagnosis. Related material can be found in the following topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5927.html" rel="external">"Approach to the child with anemia"</a>.)</p><p></p><p class="headingAnchor" id="H224100551"><span class="h1">DEFINITIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron deficiency</strong> refers to a state in which there is insufficient total body iron to maintain normal physiologic functions. We define this with a serum ferritin &lt;15 micrograms/L for all pediatric age groups. There is some disagreement about the most appropriate ferritin threshold for infants and young children, in whom either lower [<a href="#rid4">4,5</a>] or higher thresholds have been suggested [<a href="#rid6">6,7</a>]. Of note, these are thresholds to guide clinical decision-making and may differ from the reference range used by individual clinical laboratories.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia</strong> is typically defined as a hemoglobin concentration that is 2 standard deviations (SD) or more below the mean for a healthy population of the same sex and age. The World Health Organization uses the following hemoglobin thresholds to define anemia [<a href="#rid3">3</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>6 months to &lt;5 years – 11 g/dL</p><p class="bulletIndent3"><span class="glyph">-</span>5 to &lt;12 years – 11.5 g/dL</p><p class="bulletIndent3"><span class="glyph">-</span>12 to &lt;15 years – 12 g/dL</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Females ≥15 years:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Nonpregnant – 12 g/dL</p><p class="bulletIndent3"><span class="glyph">-</span>Pregnant – 11 g/dL</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Males ≥15 years – 13 g/dL</p><p></p><p class="bulletIndent1">The same hemoglobin thresholds should be utilized regardless of the patient's race or ethnicity. For individuals living at altitude, use of these thresholds may lead to underdiagnosis of anemia [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron deficiency anemia (IDA)</strong> in children can thus be defined as:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children 6 months to &lt;5 years:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ferritin &lt;15 micrograms/L, <strong>and</strong></p><p class="bulletIndent3"><span class="glyph">-</span>Hemoglobin &lt;11 g/dL (for children 0.5 to 5 years)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children 5 to &lt;12 years:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Ferritin &lt;15 micrograms/L, <strong>and</strong></p><p class="bulletIndent3"><span class="glyph">-</span>Hemoglobin &lt;11.5 g/dL (for children 5 to 12 years)</p><p></p><p class="bulletIndent1">These definitions are common but not universally used; some experts use slightly higher hemoglobin and ferritin cutoffs as thresholds for initiating an evaluation and defining IDA, respectively [<a href="#rid6">6,9</a>]. The extent of the evaluation needed depends on the likelihood of IDA in the population and on the clinical history of the individual patient.</p><p></p><p class="headingAnchor" id="H5261086"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>In the United States, up to 15 percent of toddlers (one to three years old) are iron deficient and up to 5 percent have iron deficiency anemia (IDA)  (<a class="graphic graphic_figure graphicRef100702" href="/d/graphic/100702.html" rel="external">figure 1</a>) [<a href="#rid10">10,11</a>]. The overall rate of iron deficiency in young children has declined only slightly during the past four decades but improved markedly in some subgroups. As an example, rates of iron deficiency among children 12 to 24 months old declined from 23 to 11 percent between two study periods (1976 to 1980 and 1999 to 2002) [<a href="#rid12">12</a>]. Rates decrease with advancing age until adolescence, when up to 16 percent of girls develop iron deficiency and 3 percent have IDA.</p><p>In the United States, the prevalence of iron deficiency is higher among children living at or below the poverty level and in certain racial and ethnic groups due to nonmedical drivers of health [<a href="#rid12">12-15</a>]. Young Hispanic/Latin American children have approximately double the rates of iron deficiency compared with White children [<a href="#rid13">13</a>]. Asian American children and children from families recently immigrating to the United States also have higher rates of iron deficiency. Other risk factors include low birth weight, prematurity, and childhood obesity [<a href="#rid12">12,15-17</a>]. These findings demonstrate the need for ongoing surveillance and early intervention to prevent iron deficiency during infancy and early childhood, particularly among high-risk groups.</p><p>In resource-limited countries, anemia is a common public health problem. In most of Africa, Latin America, and Southeast Asia, prevalence of anemia ranges from 45 to 65 percent in children  (<a class="graphic graphic_figure graphicRef100704" href="/d/graphic/100704.html" rel="external">figure 2</a>), 35 to 40 percent in women, and 10 to 35 percent in men [<a href="#rid18">18,19</a>]. From one-third to one-half of the anemia is thought to be attributable to iron deficiency, depending on the region [<a href="#rid1">1,2</a>].</p><p class="headingAnchor" id="H224100565"><span class="h1">PATHOPHYSIOLOGY AND RISK FACTORS</span></p><p class="headingAnchor" id="H2"><span class="h2">Iron balance</span><span class="headingEndMark"> — </span>Iron is an essential nutrient. Approximately 75 percent is bound in the heme proteins hemoglobin and myoglobin. The remainder is bound in storage proteins such as ferritin and hemosiderin, and a small portion (3 percent) is bound in critical enzyme systems, such as catalase and cytochromes [<a href="#rid20">20</a>]. In healthy adults, only 1 to 2 mg of daily iron is required from dietary sources to maintain balance with the iron loss that occurs from the gastrointestinal tract. The majority of iron needs are met by efficient iron recycling, which occurs via the breakdown of older red blood cells by macrophages within the reticuloendothelial system. However, in infants and children, 30 percent of daily iron needs must come from diet because of the rapid growth and increase in body (muscle) mass that occurs during this age range.</p><p>Iron homeostasis is primarily regulated at the site of intestinal absorption and transport. Absorption is regulated by the peptide hormone hepcidin, which acts primarily on ferroportin, the transmembrane protein that is found on the basolateral surface of enterocytes and is responsible for iron uptake into the plasma from the intestine [<a href="#rid21">21</a>]. Serum hepcidin expression, and therefore intestinal iron absorption, is influenced by body iron stores, erythropoietic rate, and states of inflammation. Low iron stores result in hepcidin suppression, allowing for enhanced iron absorption and transport. Conversely, normal iron status results in higher levels of hepcidin and decreased iron absorption. There is no mechanism for active iron excretion from the body. The steps involved in the regulation of iron metabolism are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7105.html" rel="external">"Regulation of iron balance"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Perinatal risk factors</span><span class="headingEndMark"> — </span>At birth, healthy term infants have iron stores of approximately 75 mg/kg (two-thirds of which is bound in hemoglobin) and mean hemoglobin concentrations of 15 to 17 g/dL. These infants generally have sufficient iron to support growth and development for the first four to six months of life [<a href="#rid22">22,23</a>].</p><p>Several conditions in the perinatal period can increase the risk for iron deficiency anemia (IDA) during the first three to six months of life by reducing the iron stores at birth or through other mechanisms  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Maternal iron deficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Fetal-maternal hemorrhage (FMH)</p><p class="bulletIndent1"><span class="glyph">●</span>Twin-twin transfusion syndrome (TTTS)</p><p class="bulletIndent1"><span class="glyph">●</span>Other perinatal hemorrhagic events</p><p class="bulletIndent1"><span class="glyph">●</span>Prematurity</p><p class="bulletIndent1"><span class="glyph">●</span>Administration of erythropoietin (EPO) for anemia of prematurity</p><p class="bulletIndent1"><span class="glyph">●</span>Insufficient dietary intake of iron during early infancy</p><p></p><p>The majority of maternal-fetal iron transfer occurs during the third trimester of pregnancy. For this reason, both maternal iron deficiency during pregnancy and premature birth increase the risk of iron deficiency in the infant [<a href="#rid24">24</a>]. In populations in which maternal iron deficiency is common, iron supplementation during pregnancy is beneficial [<a href="#rid25">25</a>]. The efficacy of food fortification strategies for pregnant women has not been established [<a href="#rid26">26,27</a>].</p><p>Premature infants are at increased risk of IDA due to less maternal-fetal iron transfer, smaller total blood volume at birth, blood loss through phlebotomy, and poor gastrointestinal absorption [<a href="#rid28">28</a>]. The more premature the infant, the lower his or her iron stores at birth. The use of erythropoietin to prevent and treat the anemia of prematurity further increases the risk for iron deficiency [<a href="#rid23">23</a>]. Therefore, some form of iron supplementation is recommended for all preterm infants. Perinatal hemorrhage (FMH or TTTS) in any infant further increases the risk for developing IDA early in infancy because the hemorrhage further reduces iron stores at birth. (See  <a class="medical medical_review" href="/d/html/4962.html" rel="external">"Anemia of prematurity (AOP)", section on 'Management'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Dietary factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common dietary factors</strong> – Dietary issues are the primary cause of IDA in infancy and early childhood  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>). Common factors leading to an imbalance in iron status include [<a href="#rid29">29</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Insufficient iron intake</p><p class="bulletIndent2"><span class="glyph">•</span>Inefficient absorption due to dietary sources of iron with low bioavailability</p><p class="bulletIndent2"><span class="glyph">•</span>Introduction of unmodified cow's milk (nonformula cow's milk) before 12 months of age [<a href="#rid30">30-33</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Occult blood loss secondary to cow's milk protein-induced colitis</p><p class="bulletIndent2"><span class="glyph">•</span>Obesity</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Insufficient iron intake in infants</strong> – Insufficient iron intake in infants less than 12 months of age is typically due to either breastfeeding without initiation of adequate iron supplementation by six months of age, formula with insufficient iron fortification, or early transition to cow's milk [<a href="#rid32">32-34</a>]. Human milk has low iron content but high bioavailability (50 percent), so it provides sufficient iron until approximately four months of age. Standard infant formulas have much higher concentrations of iron (at least 6.7 mg/L of iron, most with 12 mg/L), with lower bioavailability (5 percent) [<a href="#rid35">35</a>]. Most formulas with iron content below 6.7 mg/L have been removed from the market in the United States.</p><p></p><p class="bulletIndent1">Insufficient iron intake is common in breastfed infants 6 to 12 months of age, despite contributions from complementary foods such as iron-fortified cereal. In the United States, the mean estimated absorbed iron for these infants was 0.3 mg/day, below the recommended intake of 0.69 mg/day [<a href="#rid36">36</a>]. These findings support the recommendation for iron supplementation for breastfed infants beginning between four and six months of age, in addition to iron-rich complementary foods beginning at approximately six months of age. (See <a class="local">'Recommendations for iron supplementation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Insufficient iron absorption</strong> – Intestinal iron absorption is dependent on the form of iron ingested (heme versus nonheme iron) and the other foods consumed at the same time. Heme dietary sources (fish, poultry, and meat) have a higher bioavailability of iron than do nonheme (vegetable) sources (30 versus 10 percent)  (<a class="graphic graphic_table graphicRef83735" href="/d/graphic/83735.html" rel="external">table 2</a>). Other dietary components can affect iron absorption  (<a class="graphic graphic_table graphicRef64874" href="/d/graphic/64874.html" rel="external">table 3</a>). Ascorbic acid (vitamin C) enhances absorption of nonheme iron from cereal, breads, fruits, and vegetables. Conversely, absorption is inhibited by tannates (teas), bran foods rich in phosphates, and phytates (plant fiber, especially in seeds and grains) [<a href="#rid20">20,37-41</a>]. Therefore, children with vegan or vegetarian diets are at higher risk for iron deficiency compared with those with less restrictive diets. (See  <a class="medical medical_review" href="/d/html/5353.html" rel="external">"Vegetarian diets for children", section on 'Iron'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unmodified cow's milk in infancy</strong> – Early introduction of unmodified (nonformula) cow's milk during infancy is an important risk factor for IDA. Unmodified cow's milk increases intestinal blood loss in infants compared with formula or breastfeeding [<a href="#rid30">30-34</a>]. One study of infants five to six months of age found that those who switched to cow's milk had an increase in guaiac-positive stools (3 to 30 percent) during the first 28 days, while it remained low (5 percent) in those receiving a cow's milk-based infant formula [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/5897.html" rel="external">"Food protein-induced allergic proctocolitis of infancy"</a>.)</p><p></p><p class="bulletIndent1">Excessive ingestion of cow's milk (drinking more than 24 oz [720 mL] of milk daily) in young children is also an important risk factor for iron deficiency due to the low concentration and low bioavailability of iron in cow's milk, in contrast with the high bioavailability (50 percent) of iron in breast milk. Children with excessive milk intake are also at increased risk for occult intestinal blood loss [<a href="#rid42">42,43</a>]. Patients with a severe form of this syndrome can develop a protein-losing enteropathy in which albumin and total protein are low, resulting in edema and anasarca, in addition to IDA [<a href="#rid44">44</a>]. Children with prolonged bottle-feeding have higher milk consumption and increased risk of IDA compared with those who switch to a cup. As an example, one study found that children who bottle-fed during the second and third years of life had an adjusted relative risk (RR) for iron deficiency of 2.5 (95% CI 2.46-2.53), compared with those who transitioned to cups [<a href="#rid45">45</a>]. Bottle-feeding appears to be a particularly important contributor to iron deficiency among Mexican American toddlers [<a href="#rid13">13,46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obesity</strong> – Data from the National Health and Nutrition Examination Survey III (NHANES III) and other studies have demonstrated an increased prevalence of iron deficiency in children with obesity [<a href="#rid16">16,17,47</a>]. The etiology of iron deficiency in these children may be multifactorial and include increased iron requirements as well as the effects of obesity on hepcidin levels, resulting in either an inflammation-mediated functional iron deficiency and/or a diminished response to oral iron therapy and impaired iron absorption [<a href="#rid48">48-50</a>].</p><p></p><p class="headingAnchor" id="H5260705"><span class="h2">Gastrointestinal disease</span><span class="headingEndMark"> — </span>Dietary iron is absorbed primarily within the duodenum. Malabsorption of iron may occur in diseases affecting the duodenum, including celiac disease; Crohn disease, giardiasis; or any surgical resection of the proximal small intestine, such as in infants and children with intestinal failure, including short bowel syndrome [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/5899.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of celiac disease in children"</a> and  <a class="medical medical_review" href="/d/html/5886.html" rel="external">"Chronic complications of short bowel syndrome in children", section on 'Nutritional complications'</a>.)</p><p>Conditions that cause gastrointestinal blood loss, such as cow's milk protein-induced colitis, inflammatory bowel disease (IBD), or chronic use of <a class="drug drug_pediatric" data-topicid="12829" href="/d/drug information/12829.html" rel="external">aspirin</a> or nonsteroidal antiinflammatory drugs, are also associated with iron deficiency. (See  <a class="medical medical_review" href="/d/html/5904.html" rel="external">"Lower gastrointestinal bleeding in children: Causes and diagnostic approach"</a> and  <a class="medical medical_review" href="/d/html/5857.html" rel="external">"Approach to upper gastrointestinal bleeding in children", section on 'Etiology'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">PREVENTION OF IRON DEFICIENCY</span></p><p class="headingAnchor" id="H4233091828"><span class="h2">Recommended intake</span><span class="headingEndMark"> — </span>Recommended dietary allowances (RDA) for iron are based on requirements for absorbed iron, the proportion of dietary iron that is absorbed, and estimated iron losses (eg, due to menstruation). In infants and children, a substantial portion of this requirement is attributable to increases in hemoglobin mass and tissue iron due to growth. The RDA for iron in children under 12 years of age are [<a href="#rid29">29,52,53</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Infants:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Full term – 1 mg/kg daily (maximum 15 mg)</p><p class="bulletIndent2"><span class="glyph">•</span>Premature – 2 to 4 mg/kg daily (maximum 15 mg)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>1 to 3 years old – 7 mg daily</p><p class="bulletIndent2"><span class="glyph">•</span>4 to 8 years old – 10 mg daily</p><p class="bulletIndent2"><span class="glyph">•</span>9 to 13 years old – 8 mg daily</p><p></p><p>Because only a fraction of dietary iron is absorbed, the dietary requirement is considerably higher than the net absorbed iron requirement, which is dependent on the bioavailability of the iron in the food. For example, breast milk contains only 0.3 to 1.0 mg/L iron but has high bioavailability (50 percent). By contrast, proprietary iron-containing formulas typically have 12 mg/L iron but low bioavailability (4 to 6 percent) [<a href="#rid54">54</a>].</p><p>Iron requirements in adolescents are discussed separately. (See  <a class="medical medical_review" href="/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents", section on 'Iron requirements'</a>.)</p><p class="headingAnchor" id="H224102443"><span class="h2">Recommendations for iron supplementation</span><span class="headingEndMark"> — </span>Iron requirements for infants listed above are met when infants are fed an appropriate iron-fortified infant formula.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>For breastfed infants</strong>, an additional iron source (complementary foods or iron supplement) should be added at the following ages and doses [<a href="#rid29">29,52</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Full-term infants – Start an iron supplement between four and six months of age (elemental iron 1 mg/kg daily, maximum 15 mg). Continue the supplement until the infant is taking sufficient quantities of iron-rich complementary foods (eg, two or more servings of iron-fortified infant cereal daily).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Premature infants – Start an iron supplement by two weeks of age (elemental iron 2 mg/kg daily, maximum 15 mg). Continue to provide iron at a dose of at least 2 mg/kg per day, via supplements or fortified formula, through the first year of life. (See  <a class="medical medical_review" href="/d/html/5035.html" rel="external">"Breastfeeding the preterm infant", section on 'Vitamin D and iron supplements'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In populations with a high prevalence of iron deficiency</strong> (typically resource-limited countries), universal iron supplementation is recommended for infants and children 6 months to 12 years. The recommended dose and schedule is outlined in guidelines from the World Health Organization:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For infants and children in high-risk populations (prevalence of anemia &gt;40 percent) – <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F204712%2F9789241549523_eng.pdf&amp;token=SxgXcFriSCDpQMjCe5sRI5vh6QJwcXyGw2%2BVEMO5TzKuBGe3N16d9GKsSOcZsj9cv9RJbEN3JS%2BJa%2FpO2ByY8qiCbNbiiukOhMRM6tmsaF0%3D&amp;TOPIC_ID=5925" target="_blank">Daily iron supplementation</a> [<a href="#rid55">55</a>]. Supplements should not be given to children who lack access to malaria-prevention strategies, because they may increase susceptibility to malaria. (See <a class="local">'Associated disorders and effects of treatment'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For preschool- and school-aged children in moderate-risk populations (prevalence of anemia 20 to 40 percent) – <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F44648%2F9789241502009_eng.pdf&amp;token=VPoZtukfGiob1Zzt8kWPKAN%2BLnTepAguzV0xaxr8YAbXOEA5C03oup6LxPyBXRHHwkjegL5ZUdkYsoEK83qETldL8IYoVtajvuSSARGFxs4%3D&amp;TOPIC_ID=5925" target="_blank">Intermittent iron supplementation</a> (one supplement/week, in three-month cycles) [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1">The evidence supporting the above recommendations for iron supplementation in populations with high rates of iron deficiency is mixed. Although universal iron supplementation to infants reduces the prevalence of anemia, studies reached conflicting conclusions about whether it improves growth or neurodevelopmental outcomes, as discussed below. (See <a class="local">'Associated disorders and effects of treatment'</a> below.)</p><p></p><p class="bulletIndent1">Other strategies to prevent iron deficiency vary by region; these include food fortification (eg, iron fortification of whole maize flour, milk, noodles, or rice or as part of a multiple micronutrient powder [<a href="#rid57">57,58</a>]) and control of hookworm (helminth) infection and malaria [<a href="#rid59">59</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Dietary recommendations</span><span class="headingEndMark"> — </span>In populations with relatively low rates of iron deficiency, such as the United States, there is little evidence that routine iron supplementation is beneficial in healthy children six months and older [<a href="#rid60">60</a>]. Instead, the following general dietary measures are recommended to help meet the estimated iron requirements  (<a class="graphic graphic_table graphicRef114486" href="/d/graphic/114486.html" rel="external">table 4</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Infants:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Encourage exclusive breastfeeding for the first six months. Infants who receive greater than one-half of their nutrition from breast milk should initiate iron supplements between four and six months of age for term infants and at two weeks of age for preterm infants; the supplements should be continued until the infant is receiving sufficient iron from complementary foods or formula. (See <a class="local">'Recommended intake'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For infants less than 12 months of age who are formula fed or take less than one-half of their nutrition from breast milk, iron-fortified formulas (6 to 12 mg of iron per liter) should be provided [<a href="#rid61">61</a>]. Low-iron infant formulas (ie, those containing less than 6 mg/L of iron) should not be used [<a href="#rid35">35</a>]. Iron fortification of formula is necessary to prevent deficiency [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent2">No adverse effects of this level of iron supplementation have been demonstrated. A possibility of adverse effects on cognitive outcomes was raised by a large randomized trial performed in Chile, in which infants fed an iron-fortified formula (12 mg/L) had slightly worse long-term cognitive outcomes compared with those fed a low-iron formula (2 mg/L) [<a href="#rid62">62,63</a>]. However, the opposite effect was seen for the subset of infants with low baseline hemoglobin concentrations (&lt;10.5 g/dL). Moreover, it is important to note that this trial enrolled infants at six months of age, when most infants consume significant iron from complementary foods. Thus, the trial is not informative about the optimal concentration of iron in formula in younger infants (&lt;6 months).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>At age six months, encourage one feeding per day of foods rich in vitamin C (eg, citrus fruits, cantaloupe, strawberries, tomatoes, and dark green vegetables) to enhance iron absorption [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/d/html/2855.html" rel="external">"Introducing solid foods and vitamin and mineral supplementation during infancy", section on 'What to feed and how to advance'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After age six months, or when developmentally ready, consider introduction of pureed meats. The heme iron in meats is more bioavailable than nonheme iron and also enhances absorption of nonheme iron [<a href="#rid64">64,65</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For all infants (&lt;12 months), avoid feeding unmodified (nonformula) cow's milk or goat's milk [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children aged one to five years:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Limit cow's milk consumption to no more than 20 oz (600 mL) per day. We suggest this limit because the risk of iron deficiency increases in young children drinking more than 24 oz of milk per day [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Encourage at least three servings per day of iron-containing foods (eg, fortified breakfast cereal, 3 oz of meat, or 4 oz of tofu); children who eat less than this target usually have suboptimal iron intake and may benefit from an iron supplement [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children aged five to 12 years: Older children can consume a variety of iron-rich foods  (<a class="graphic graphic_table graphicRef83735" href="/d/graphic/83735.html" rel="external">table 2</a>) to meet their iron requirement (10 mg daily for children 4 to 8 years; 8 mg daily for those 9 to 13 years). For all age groups common iron-rich foods are fortified cereals and meats. </p><p></p><p class="headingAnchor" id="H20317248"><span class="h1">CLINICAL MANIFESTATIONS OF IRON DEFICIENCY ANEMIA</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stages of iron deficiency</strong> – Iron deficiency anemia (IDA) is a microcytic, hypochromic, and hypoproductive state. The progression from normal iron status to iron deficiency, followed by iron-limited erythropoiesis and finally to IDA, is shown in the table  (<a class="graphic graphic_table graphicRef57739" href="/d/graphic/57739.html" rel="external">table 5</a>). With iron deficiency, storage sites are depleted, but there is sufficient iron in the "labile" iron pool from the daily turnover of red cells for normal hemoglobin synthesis, unless further iron losses occur. Anemia develops only in the final stage of iron deficiency. Conversely, when iron repletion is initiated, the anemia is the first to recover and normalization of iron stores is the final thing to fully correct.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical findings</strong> – The most common presentation of IDA is an otherwise asymptomatic, well-nourished infant or child who has a mild to moderate microcytic, hypochromic anemia  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 1</a>). Some children are diagnosed in the setting of an acute illness, at which time, pallor and fatigue may be more notable. Much less frequent are infants with severe anemia, who present with lethargy, pallor, irritability, cardiomegaly, poor feeding, and tachypnea. However, some of these symptoms (decreased energy, mild pallor or yellow skin [not jaundice], and pica) may not be appreciated until the improvement is seen once a child begins iron therapy.</p><p></p><p class="bulletIndent1">Pica is the intense craving for nonfood items. Various forms of pica have been associated with iron deficiency, including clay or dirt, rocks, starch, chalk, soap, paper, cardboard, or raw rice [<a href="#rid67">67</a>]. Pagophagia, or craving for ice, is particularly common and specific for the iron-deficient state. It may be present in children who are not anemic and responds rapidly to treatment with iron, often before any increase is noted in the hemoglobin concentration [<a href="#rid68">68,69</a>]. The mechanism for the association of iron deficiency and pica is unknown.</p><p></p><p class="bulletIndent1">Pica may also occur in children between the ages of two and three with developmental disabilities, including autism and intellectual disability, as well as children with brain injuries that affect their development and is not consistently associated with iron deficiency in these populations [<a href="#rid70">70</a>]. It is also reported in children with sickle cell disease, though the mechanism in this condition is unknown as well. (See  <a class="medical medical_review" href="/d/html/6172.html" rel="external">"Intellectual disability (ID) in children: Clinical features, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/589.html" rel="external">"Autism spectrum disorder in children and adolescents: Surveillance and screening in primary care", section on 'Approach to ASD surveillance and screening'</a> and  <a class="medical medical_review" href="/d/html/627.html" rel="external">"Autism spectrum disorder in children and adolescents: Clinical features", section on 'Terminology'</a>.)</p><p></p><p class="headingAnchor" id="H4251596525"><span class="h1">ASSOCIATED DISORDERS AND EFFECTS OF TREATMENT</span><span class="headingEndMark"> — </span>Iron deficiency anemia (IDA) is associated with multiple deficits, including impaired neurodevelopment, growth, and immunity. However, it is uncertain whether iron supplementation can prevent or reverse these effects, based on evidence from clinical trials.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurodevelopment</strong> – In young children, IDA has been associated with impaired neurocognitive development, including slower visual and auditory processing [<a href="#rid71">71-79</a>]. The observed associations provide the rationale for routine supplementation to breastfed infants and subsequent screening of all infants and young children in the United States and universal iron supplementation for children in populations with high rates of IDA. (See <a class="local">'Recommendations for iron supplementation'</a> above.)</p><p></p><p class="bulletIndent1">Most clinical evidence comes from longitudinal cohort studies in low- and middle-income countries with high rates of IDA that showed associations between IDA and neurodevelopmental deficits, especially for children with more severe and chronic IDA [<a href="#rid80">80-86</a>].</p><p></p><p class="bulletIndent1">Despite the observed association, clinical trials of iron supplementation have generally failed to demonstrate benefits on neurodevelopmental outcomes or growth parameters. As an example, a large randomized trial in 3300 infants in rural Bangladesh evaluated the effects of a universal iron supplementation approach (12.5 mg elemental iron per day either alone or with multiple micronutrients, compared with placebo) given for three months starting in late infancy [<a href="#rid87">87</a>]. Approximately one-third of the infants were iron deficient and one-fifth had IDA at the onset of the study. Iron supplementation effectively reduced the prevalence of IDA. However, there were no significant differences between the three groups on neurocognitive tests, when measured after completion of the regimen (at three months) or nine months later, including in the subgroup with IDA. These findings are consistent with prior meta-analyses of randomized trials, which found inconclusive evidence for effects of iron supplementation on neurodevelopment and other functional outcomes for children &lt;24 months [<a href="#rid57">57,88</a>] or for older children [<a href="#rid55">55,56,88,89</a>].</p><p></p><p class="bulletIndent1">Possible explanations for these negative results are that the iron supplementation in late infancy was insufficient to compensate for chronic exposure to iron deficiency in utero and early infancy, that it was too low of a dose or for an insufficient period of time, or that the observed association between IDA and neurodevelopmental outcomes is not causal. Moreover, although the study was large, its power to detect a treatment effect was limited because only a minority of subjects had iron deficiency or IDA at enrollment.</p><p></p><p class="bulletIndent1">Limited data suggest that iron therapy has some benefit on other neurologic conditions in young children, including breath-holding spells, restless legs syndrome, and periodic limb movement disorder [<a href="#rid90">90-92</a>]. (See  <a class="medical medical_review" href="/d/html/16995.html" rel="external">"Restless legs syndrome and periodic limb movement disorder in children", section on 'Iron deficiency'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Febrile seizures</strong> – Several studies have demonstrated an association between febrile seizures and iron deficiency or IDA. No causal relationship between iron deficiency and development of febrile seizures has been demonstrated [<a href="#rid93">93-97</a>]. However, serum ferritin levels are significantly lower in children with febrile seizures compared with those with fever alone. Therefore, screening for iron deficiency in young children with a history of febrile seizures may be warranted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunity and infection</strong> – Data on the impact of iron supplementation on immune function and susceptibility to infection are mixed. On one hand, iron deficiency appears to be associated with mild to moderate defects in leukocyte and lymphocyte function, including defective interleukin-2 and -6 production [<a href="#rid98">98-102</a>]. On the other hand, iron supplementation may paradoxically increase the risk for certain types of infection. In particular, iron supplementation may increase the risk for bacterial infection because the iron-binding proteins transferrin and lactoferrin have bacteriostatic effects, which are lost when they are saturated with iron [<a href="#rid101">101</a>]. Similarly, there is some evidence that iron supplementation results in increased susceptibility to or reactivation of dormant infections, such as malaria or tuberculosis [<a href="#rid103">103</a>].</p><p></p><p class="bulletIndent1">The clinical relevance of these observations is unclear. Some studies suggest the susceptibility to malaria is only relevant in endemic areas and high-transmission seasons; other than in this group, standard doses of iron supplements do not appear to significantly increase the risk for malaria [<a href="#rid102">102,104</a>]. In confirmation of this finding, a large meta-analysis found that iron supplementation does not increase the risk of clinical malaria or death when regular malaria surveillance and treatment services are provided [<a href="#rid105">105</a>]. Furthermore, in a systematic review of randomized trials (most of which were in populations at risk for malaria and diarrheal disease), iron supplementation was associated with a higher risk of diarrhea but had no apparent harmful effect on the incidence of malaria or other infectious illnesses in children [<a href="#rid106">106</a>].</p><p></p><p class="bulletIndent1">A study in Kenyan infants demonstrated that those who were iron deficient at the time of vaccination had a decreased humoral response to vaccines [<a href="#rid107">107</a>]. Iron supplementation at the time of vaccination resulted in an improved humoral response to vaccines. These findings further support the role of iron in optimal immune response.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exercise capacity</strong> – Moderately severe IDA is associated with decreased work capacity, in part because iron is an essential cofactor for enzyme-driven aerobic metabolism. Decreased iron stores, in the absence of anemia, is associated with decreased exercise performance in laboratory animals. Similar findings have been noted in children, particularly adolescent athletes. (See  <a class="medical medical_review" href="/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents", section on 'Physical performance and fatigue'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombosis/stroke</strong> – IDA has been associated with cerebral vein thrombosis [<a href="#rid108">108</a>]. In a large case-control study from a comprehensive Stroke Registry in Canada, previously healthy children with stroke (arterial or venous) were 10 times more likely to have IDA than healthy children without stroke [<a href="#rid109">109</a>]. The mechanisms for this complication are not clear but may be related to thrombocytosis (platelet counts approaching 1 million/uL) that is sometimes present in IDA or as a result of abnormal rheologic properties in children with severe IDA. One case report describes a fatal stroke in a young child with severe IDA and no other thrombophilia risk factors [<a href="#rid110">110</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h1">SCREENING RECOMMENDATIONS</span></p><p class="headingAnchor" id="H1571386418"><span class="h2">Indications and timing</span><span class="headingEndMark"> — </span>We suggest routine screening for iron deficiency anemia (IDA) in all infants 4 to 36 months of age, consisting of regular clinical risk assessment at well-child visits and laboratory testing at times of highest risk, as outlined below. (See <a class="local">'Risk assessment'</a> below and <a class="local">'Laboratory screening'</a> below.)</p><p>Guidelines differ in their recommendations about the utility of routine <strong>universal</strong> <strong>laboratory screening</strong> in resource-abundant settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Our suggestion for routine universal laboratory screening is consistent with recommendations from the American Academy of Pediatrics (AAP) [<a href="#rid29">29,52</a>]. The rationale is that indirect evidence from populations with moderate or high rates of IDA (including historical studies in the United States) suggest important health benefits, such as prevention of neurocognitive deficits. Moreover, symptoms and risk factors are not reliable factors for selective screening strategies in young children.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other societies, including the United States Preventive Services Task Force and guidelines in Canada and the United Kingdom, do not recommend universal laboratory screening for IDA in young children, citing lack of direct evidence of the benefits or the harms of this approach [<a href="#rid111">111-113</a>]. No studies adequately assess the impact of routine screening and iron supplementation in the United States and other similar countries. Furthermore, available screening tests (such as point-of-care measurements of hemoglobin) have only fair accuracy in identifying IDA (positive predictive value 10 to 40 percent at 12 months of age) [<a href="#rid111">111</a>].</p><p></p><p>Of note, all of the above societies recommend <strong>targeted</strong> <strong>laboratory screening</strong> for IDA in infants and children with risk factors, including those with malnutrition, prematurity, low birth weight, dietary risk factors, obesity, or symptoms of IDA  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>).</p><p>In resource-limited settings with a high population frequency of iron deficiency (40 percent or higher), universal daily iron supplementation is recommended (except in children with high risks for malaria), as outlined in a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F204712%2F9789241549523_eng.pdf&amp;token=SxgXcFriSCDpQMjCe5sRI5vh6QJwcXyGw2%2BVEMO5TzKuBGe3N16d9GKsSOcZsj9cv9RJbEN3JS%2BJa%2FpO2ByY8qiCbNbiiukOhMRM6tmsaF0%3D&amp;TOPIC_ID=5925" target="_blank">guideline</a> from the World Health Organization [<a href="#rid55">55</a>]; intermittent iron supplementation is recommended for populations at moderate risk [<a href="#rid56">56</a>]. (See <a class="local">'Recommendations for iron supplementation'</a> above.)</p><p class="headingAnchor" id="H20316585"><span class="h2">Risk assessment</span><span class="headingEndMark"> — </span>The AAP suggests performing a brief review of IDA risk factors for all infants at all well-child evaluations from 4 to 36 months of age and annually thereafter [<a href="#rid29">29,52</a>].</p><p>The assessment should review the primary risk factors for iron deficiency  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>), which are [<a href="#rid52">52</a>] (see <a class="local">'Dietary recommendations'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>Young infants – A history of prematurity or low birth weight, or administration of erythropoietin for anemia of prematurity (see <a class="local">'Perinatal risk factors'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Under 12 months – Use of "low-iron" formula, nonformula cow's milk, goat's milk, or soy milk before 12 months of age; fewer than two servings/day of iron-rich foods (meats or fortified infant cereal) after six months of age</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>12 months and older – Milk intake greater than 24 oz daily; fewer than three servings daily of iron-rich foods (eg, iron-fortified breakfast cereal or meats) (see <a class="local">'Dietary factors'</a> above)</p><p></p><p>A focused dietary history is an important screening tool and is more accurate than an isolated measurement of hemoglobin level for identifying children with iron deficiency and IDA. As an example, a study in 305 healthy African American children age one to five years found that a brief dietary history was an effective screening test for microcytic anemia [<a href="#rid114">114</a>]. Specifically, a normal dietary history had a negative predictive value of 97 percent. In this study, dietary risk for iron deficiency was defined as one or more of the following: more than 480 mL (16 oz) of milk per day; less than five servings each of meat, grains, vegetables, and fruit per week; or daily intake of fatty snacks, sweets, or more than 480 mL (16 oz) of soft drink.</p><p class="headingAnchor" id="H20316572"><span class="h2">Laboratory screening</span><span class="headingEndMark"> — </span>The AAP suggests universal laboratory screening for IDA at approximately 9 to 12 months of age and repeated screens for children with risk factors (or a few months later for formula-fed infants) [<a href="#rid29">29,52</a>].</p><p>Screening at one year of age is particularly important in children who are primarily breastfed and in populations with increased risks of iron deficiency, including communities with low income levels (eg, those who receive support from the Women, Infants, and Children [WIC] program). Children receiving iron-fortified formula during the first year of life are at low risk for iron deficiency at one year of age. Such children may have higher risk beyond 12 months of age after transition from iron-fortified formula to cow's milk.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong> – The screening protocol depends on the child's risk factors:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For all children, perform laboratory screening at 9 to 12 months of age. For those who are fed an iron-fortified formula, it may be appropriate to delay the screen until approximately 15 to 18 months of age. This timing will better capture the child's iron status after transitioning from formula to cow's milk.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For children with risk factors for iron deficiency (eg, history of prematurity or dietary risk factors such as excessive milk intake  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>)) – Test again, eg, at 15 to 18 months of age or when risk is identified.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For children with special health needs (chronic infection, inflammatory disorders, chronic gastrointestinal dysfunction, history of intestinal surgery, or restricted diets) – Repeat laboratory screening at 15 to 18 months of age, and again in early childhood, eg, between two to five years of age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Method</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complete blood count (CBC)</strong> – In most clinical settings, the simplest and most cost-effective measurement is a CBC, which will include measurements of hemoglobin, mean corpuscular volume (MCV), and red blood cell distribution width (RDW; a measure of variability in red cell size). In IDA, MCV usually is decreased and RDW increased  (<a class="graphic graphic_table graphicRef65701" href="/d/graphic/65701.html" rel="external">table 6</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemoglobin concentration</strong> – In settings in which a full CBC cannot be performed, the minimum laboratory screen for IDA is measurement of hemoglobin. Common definitions of low hemoglobin are &lt;11 g/dL in children 0.5 to &lt;5 years of age and &lt;11.5 g/dL in children 5 to &lt;12 years. Note that children with a normal hemoglobin may have iron deficiency that is not revealed by measurement of hemoglobin alone. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Serum ferritin</strong> – If feasible within the clinical setting in which the child is being seen, we suggest measuring serum ferritin at the time of the initial screen to assess for iron deficiency in addition to anemia. This facilitates the diagnosis and will identify children who are iron deficient but not yet anemic [<a href="#rid4">4,29</a>]. In the majority of otherwise healthy children, serum ferritin is a reliable measure of iron status. However, because ferritin is an acute phase reactant, it can be falsely normal or elevated in children with a concurrent acute infection or chronic comorbid condition, even if the child is iron deficient. Importantly, a low ferritin level is always consistent with iron deficiency. (See <a class="local">'Laboratory testing'</a> below.)</p><p></p><p>In resource-limited settings with a high population frequency of anemia, universal iron supplementation is recommended rather than laboratory screening. (See <a class="local">'Recommendations for iron supplementation'</a> above.)</p><p>Screening recommendations for adolescents are presented separately. (See  <a class="medical medical_review" href="/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents", section on 'Screening'</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">EVALUATION FOR SUSPECTED IRON DEFICIENCY ANEMIA</span><span class="headingEndMark"> — </span>Children with a laboratory finding of anemia (hemoglobin &lt;11 g/dL for 0.5 to &lt;5 years of age; &lt;11.5 g/dL for 5 to 12 years) should be further evaluated to determine the underlying etiology, whether iron deficiency or another cause.</p><p>To confirm the diagnosis of iron deficiency anemia (IDA), particularly when a hemoglobin alone or complete blood count (CBC) demonstrating a microcytic anemia is identified but without a confirmatory serum ferritin, we suggest the following additional steps  (<a class="graphic graphic_algorithm graphicRef114480" href="/d/graphic/114480.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Review history</strong> (see <a class="local">'Focused history'</a> below)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For risk factors for IDA (dietary, blood loss, obesity, or malabsorptive disease)  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>For evidence of other causes of anemia (acute infection, chronic diseases, or family history of anemia or hemoglobinopathy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial laboratory testing</strong> – If the history is consistent with likely or possible IDA, performing a limited laboratory evaluation can confirm the diagnosis. If the presentation is typical for IDA (age &lt;3 years, with any dietary risk factors for IDA), a CBC demonstrating a microcytic anemia is sufficient to make the diagnosis. If the presentation is atypical, more extensive laboratory testing may be appropriate. (See <a class="local">'Laboratory testing'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trial of iron therapy</strong> – If the history and laboratory testing is consistent with IDA, perform an empiric trial of iron therapy. (See <a class="local">'Empiric trial of iron therapy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reevaluate</strong> within four weeks to confirm a response to the iron therapy.</p><p></p><p>These additional steps are important because an isolated low hemoglobin concentration is neither a sensitive nor a specific screen for iron deficiency [<a href="#rid29">29,115</a>]. The proportion of anemia that is caused by iron deficiency is considerably higher in populations with risk factors for iron deficiency in the United States and elsewhere.</p><p class="headingAnchor" id="H4055869167"><span class="h2">Focused history</span><span class="headingEndMark"> — </span>A focused history is a critical step to fully assess risk factors and etiology for IDA, as well as exclude other causes of anemia. The key elements depend on the child's age  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>). The history can be used to categorize patients by their likelihood for having nutritional IDA:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Typical presentation of nutritional IDA</strong> (all of the following):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age nine months to three years</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One or more risk factors for nutritional IDA</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Lack of iron supplementation in breastfed infants (starting by four to six months in term infants or by two weeks of age for preterm infants), feeding of low-iron formula or unmodified (nonformula) cow's milk, and insufficient iron-rich complementary foods after four to six months of age</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In toddlers and young children (12 months or older), dietary risk factors include excessive intake of cow's milk (&gt;20 oz [600 mL] daily) and insufficient consumption of iron-rich foods</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Otherwise healthy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atypical presentation of nutritional IDA</strong> (any of the following):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Age 3 to 12 years</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>No dietary risk factors for iron deficiency</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Features suggesting non-nutritional cause of IDA (due to blood loss or malabsorption):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Marked blood loss – eg, frequent nose bleeds, grossly bloody stools, or menorrhagia in girls who are menstruating</p><p class="bulletIndent3"><span class="glyph">-</span>Disorders associated with iron malabsorption – eg, celiac disease or inflammatory bowel disease (IBD)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Features suggesting other causes of anemia, including:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Other systemic disorders associated with anemia – eg, systemic inflammatory disorders or cancer</p><p class="bulletIndent3"><span class="glyph">-</span>Acute or recurrent infections consistent with anemia of inflammation</p><p class="bulletIndent3"><span class="glyph">-</span>Family history of anemia or hemoglobinopathy, such as thalassemia trait</p><p></p><p>If the history suggests a specific cause of anemia other than IDA (eg, systemic disease or hemoglobinopathy) or if there is evidence of marked blood loss, a targeted evaluation or referral may be appropriate (see  <a class="medical medical_review" href="/d/html/5927.html" rel="external">"Approach to the child with anemia"</a>). Otherwise, the next step is focused laboratory testing, as described in the next section. (See <a class="local">'Laboratory testing'</a> below.)</p><p class="headingAnchor" id="H717394838"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>If the history is consistent with IDA, perform a limited laboratory evaluation to confirm the presence of a microcytic anemia  (<a class="graphic graphic_algorithm graphicRef114480" href="/d/graphic/114480.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H3962502766"><span class="h3">Selection of tests</span><span class="headingEndMark"> — </span>The extent of the laboratory testing depends on patient characteristics and the history:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Typical presentation of IDA</strong> – If the presentation is typical for nutritional IDA (age &lt;3 years, with any dietary risk factors for IDA), a CBC is sufficient, although measuring serum ferritin provides additional valuable information.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atypical presentation for IDA</strong> – If the presentation is atypical (age 3 to 12 years or no dietary risk factors or other possible risk factors present), somewhat more extensive laboratory testing is appropriate because nutritional IDA is less common in these patients. In our program, we perform a CBC with indices, reticulocyte count, serum ferritin, and peripheral blood smear. Providers may also consider testing stools for occult blood.</p><p></p><p>In addition, a blood lead level should be measured if there are any risk factors for lead exposure or symptoms of pica [<a href="#rid29">29,116,117</a>]. (See  <a class="medical medical_review" href="/d/html/2872.html" rel="external">"Screening tests in children and adolescents", section on 'Lead poisoning'</a>.)</p><p>If the results of these tests are consistent with IDA, the next step is a therapeutic trial of iron and further evaluation is performed only if the response is inadequate. Patients with nutritional IDA should have dietary counseling to address the underlying etiology  (<a class="graphic graphic_table graphicRef114486" href="/d/graphic/114486.html" rel="external">table 4</a>). Patients with any evidence of gastrointestinal blood loss or malabsorption should be started on iron supplements and referred to a gastroenterologist for further evaluation. (See <a class="local">'Empiric trial of iron therapy'</a> below.)</p><p class="headingAnchor" id="H3887662090"><span class="h3">Interpretation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis of IDA</strong> – The following findings support a diagnosis of IDA  (<a class="graphic graphic_table graphicRef65701" href="/d/graphic/65701.html" rel="external">table 6</a>) [<a href="#rid118">118,119</a>] (see <a class="local">'Definitions'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Microcytic anemia</strong> on CBC (low hemoglobin, low mean corpuscular volume [MCV], and elevated red cell distribution width [RDW])</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Low serum ferritin</strong> (&lt;15 micrograms/L)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role for other laboratory tests</strong> – Several additional iron measures are available to evaluate for IDA. However, all iron tests must be interpreted with the full clinical context and patient history since most measures can be affected by factors other than iron status  (<a class="graphic graphic_table graphicRef82013" href="/d/graphic/82013.html" rel="external">table 7</a>). A low serum ferritin is always consistent with iron deficiency, but normal or elevated ferritin does not exclude iron deficiency. Ferritin is an acute phase reactant and may be increased in states of liver disease, inflammation (acute or chronic), obesity, and malignancy. Thus, a patient with iron deficiency and a concomitant inflammatory disease, or even an acute infection such as acute otitis media, may have a "falsely" normal ferritin concentration. In patients with a concurrent infection at the time of testing, a measure of inflammation, such as C-reactive protein (CRP), may be assessed to validate the results of serum ferritin [<a href="#rid52">52,120</a>]. However, this test is not routinely indicated in patients who are healthy (see  <a class="medical medical_review" href="/d/html/7483.html" rel="external">"Acute phase reactants"</a>). Of note, the reticulocyte hemoglobin content (CHr) or equivalent (Ret-He) reflect the hemoglobin content in reticulocytes and low values reliably indicate early iron deficient erythropoiesis, prior to onset of anemia [<a href="#rid121">121,122</a>]. However, the CHr/Ret-He is also low in patients with thalassemia trait.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Other conditions can produce a mild hypochromic, microcytic anemia and may be misinterpreted as IDA or coexist with IDA, including [<a href="#rid123">123,124</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia of inflammation – Mild anemia (decline of 0.5 to 2.0 g/dL) following a recent infection or immunization.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hemoglobinopathies, including alpha or beta thalassemia traits, hemoglobin C or E trait – Children with thalassemia trait may have a microcytic anemia. In children with both thalassemia trait and IDA, appropriate iron therapy will improve measures of iron stores and may modestly improve the hemoglobin concentration, but microcytosis with or without a mild anemia may persist.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia of chronic disease – Longstanding chronic inflammatory diseases can result in iron-restricted erythropoiesis, which is similar but distinct from classic IDA. Both conditions may have microcytic anemia on complete blood count (CBC), but chronic inflammation will result in a different pattern on laboratory tests in the iron panel and often improves as inflammation decreases.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Combined nutritional anemias – In patients with iron deficiency and concomitant vitamin B12 or folate deficiency it may be difficult to categorize the anemia using red blood cell indices. These combined nutritional anemias are rare in otherwise healthy children.</p><p></p><p class="bulletIndent1">A method to distinguish among the more common conditions is noted in the table  (<a class="graphic graphic_table graphicRef65701" href="/d/graphic/65701.html" rel="external">table 6</a>). These conditions should be considered in patients with predisposing factors and in children who fail to respond to a therapeutic trial of iron. Children with known thalassemia trait should always have iron measures (ie, serum ferritin) assessed prior to initiation of iron therapy. (See  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment", section on 'Nonresponders'</a> and  <a class="medical medical_review" href="/d/html/5927.html" rel="external">"Approach to the child with anemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contributing factors</strong> – Although IDA is typically caused by insufficient dietary iron, it is sometimes caused by an underlying medical problem resulting in gastrointestinal blood loss, malabsorption syndrome, or menstrual blood loss in a postmenarchal girl, each of which should be assessed on history. As an example, refractory IDA can be the presenting symptom of celiac disease [<a href="#rid125">125</a>], <em>Helicobacter</em> <em>pylori</em> infection [<a href="#rid126">126</a>], or inflammatory bowel disease (refer to appropriate UpToDate topic reviews).</p><p></p><p class="headingAnchor" id="H3039996807"><span class="h2">Empiric trial of iron therapy</span><span class="headingEndMark"> — </span>For infants and children with a presumptive diagnosis of IDA based on the history and initial laboratory testing, the next step is a therapeutic trial of iron, consisting of the following steps  (<a class="graphic graphic_algorithm graphicRef114480" href="/d/graphic/114480.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Initiate <a class="drug drug_pediatric" data-topicid="13056" href="/d/drug information/13056.html" rel="external">ferrous sulfate</a>, 3 mg/kg of elemental iron, once daily in the morning or between meals. Iron may be given alone or with water or orange juice, with care to ensure that the entire dose is taken. Milk and/or dairy products should be avoided for approximately one hour before and two hours after each dose. We choose to use ferrous sulfate and the 3 mg/kg dose because it was effective in a clinical trial and may be better tolerated than higher doses that are sometimes used [<a href="#rid127">127</a>]. (See  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment", section on 'Dose and scheduling'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In addition to iron therapy, provide dietary counseling to ensure adequate intake of iron and avoid dietary risk factors such as excessive milk intake  (<a class="graphic graphic_table graphicRef114486" href="/d/graphic/114486.html" rel="external">table 4</a>). (See <a class="local">'Dietary recommendations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Confirm the response to iron therapy by a repeat CBC within four weeks from initiation of iron treatment.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An appropriate response is indicated by a rise in hemoglobin of &gt;1 g/dL within four weeks for children with mild anemia (hemoglobin 9 to 11 g/dL) [<a href="#rid29">29</a>] or within two weeks for those with moderate or severe anemia (hemoglobin &lt;9 g/dL).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children who do not display an adequate rise in hemoglobin as described above should be reevaluated. Potential causes of recurrent or refractory IDA include ineffective treatment (nonadherence or incorrect dosing), incorrect diagnosis, or blood loss or malabsorption. (See  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment", section on 'Follow-up assessment for response'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Once the response is confirmed, iron therapy and monitoring should be continued and the CBC is retested at three months. Iron therapy should be given for at least three months, and many children require longer treatment courses to replenish iron stores. In general, iron therapy should be continued for at least one month after the hemoglobin reaches the age-adjusted normal range. (See  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment", section on 'Follow-up assessment for response'</a>.)</p><p></p><p class="headingAnchor" id="H977342790"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111044.html" rel="external">"Society guideline links: Pediatric iron deficiency"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Iron deficiency is the most common nutritional deficiency in children. If iron deficiency is unrecognized, it can result in iron deficiency anemia (IDA). Children with IDA have poorer neurocognitive outcomes compared with those without IDA, but a causal effect has not been established. (See <a class="local">'Clinical manifestations of iron deficiency anemia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Measures to prevent iron deficiency and IDA include  (<a class="graphic graphic_table graphicRef114486" href="/d/graphic/114486.html" rel="external">table 4</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For breastfed infants, iron supplementation between four to six months of age for term infants and two weeks of age for premature infants. The iron supplements should be continued until the infant is taking sufficient quantities of iron-rich complementary foods, such as infant cereal.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In populations with a high prevalence of iron deficiency (age-specific prevalence of anemia &gt;40 percent), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F204712%2F9789241549523_eng.pdf&amp;token=SxgXcFriSCDpQMjCe5sRI5vh6QJwcXyGw2%2BVEMO5TzKuBGe3N16d9GKsSOcZsj9cv9RJbEN3JS%2BJa%2FpO2ByY8qiCbNbiiukOhMRM6tmsaF0%3D&amp;TOPIC_ID=5925" target="_blank">universal iron supplementation</a> for infants and children 6 months to 12 years. Supplements should not be given to children who lack access to malaria-prevention strategies, because the iron supplements may increase susceptibility to malaria.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For all children, dietary measures include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Introduce iron-rich complementary foods at four to six months of age</p><p class="bulletIndent3"><span class="glyph">-</span>Avoid unmodified (nonformula) cow's milk until age 12 months; after 12 months of age, limit milk intake to no more than 20 oz (600 mL) daily</p><p></p><p class="bulletIndent1">(See <a class="local">'Recommendations for iron supplementation'</a> above and <a class="local">'Dietary recommendations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening for risk factors</strong> – A focused dietary history is the most important screening test for detecting iron deficiency. In the United States, risk assessment for iron deficiency through a brief review of dietary risk factors  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>) is recommended at all well-child checks from four months to three years of age and annually thereafter. (See <a class="local">'Risk assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory screening</strong> – In addition, we suggest universal laboratory screening for IDA for children in the United States and similar populations, rather than selective screening for those with risk factors (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). The frequency of screening depends on patient characteristics (see <a class="local">'Laboratory screening'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All children – Screen once at 9 to 12 months of age. For those who are fed an iron-fortified formula, it may be appropriate to delay the screen until approximately 15 to 18 months of age. This timing will better capture the child's iron status after transitioning from formula to cow's milk.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High-risk children – For children at high risk for IDA by dietary history (excessive cow's milk intake) or prematurity, screen a second time several months later (eg, at 15 to 18 months or when risk is identified).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children with special health needs – For children at risk for IDA because of underlying medical conditions such as chronic infection, inflammatory disorders, chronic gastrointestinal dysfunction, restricted diets, or other significant dietary risk factors for IDA, repeat screening at 15 to 18 months of age and again in early childhood (eg, at two to five years of age).</p><p></p><p class="bulletIndent1">In most clinical settings, the simplest and most cost-effective measurement is a complete blood count (CBC). For children with substantial risk factors for iron deficiency, measuring serum ferritin at the time of the initial screen facilitates the diagnosis. (See <a class="local">'Laboratory screening'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – IDA should be suspected in children with laboratory findings of anemia (hemoglobin &lt;11 g/dL in children 0.5 to 5 years of age and &lt;11.5 g/dL in children 5 to 12 years) (see <a class="local">'Definitions'</a> above). The diagnosis can be confirmed through the following additional steps  (<a class="graphic graphic_algorithm graphicRef114480" href="/d/graphic/114480.html" rel="external">algorithm 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Review the history for risk factors for IDA and for other causes of anemia  (<a class="graphic graphic_table graphicRef114485" href="/d/graphic/114485.html" rel="external">table 1</a>). (See <a class="local">'Focused history'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the history is consistent with likely or possible IDA, perform a limited laboratory evaluation:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Typical presentation (age &lt;3 years, with any dietary risk factors for IDA) – CBC, with or without serum ferritin</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Atypical features – CBC, reticulocyte count, serum ferritin, peripheral blood smear, and stools for occult blood (see <a class="local">'Selection of tests'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The combination of a hemoglobin concentration below 11 g/dL with low serum ferritin makes the diagnosis of IDA  (<a class="graphic graphic_table graphicRef65701" href="/d/graphic/65701.html" rel="external">table 6</a>). MCV is typically low and RDW elevated [<a href="#rid118">118,119</a>]. Most of these measures can be affected by factors other than iron status  (<a class="graphic graphic_table graphicRef82013" href="/d/graphic/82013.html" rel="external">table 7</a>). (See <a class="local">'Interpretation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment trial</strong> – For children with presumed IDA (on the basis of history and initial laboratory testing), we suggest an empiric trial of oral iron therapy <strong>and</strong> dietary changes rather than either intervention alone (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest using a dose of 3 mg/kg of elemental iron, once daily between meals, rather than higher doses (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). A 3 mg/kg dose of <a class="drug drug_pediatric" data-topicid="13056" href="/d/drug information/13056.html" rel="external">ferrous sulfate</a> is generally effective and is tolerated by most children. (See <a class="local">'Empiric trial of iron therapy'</a> above and  <a class="medical medical_review" href="/d/html/15647.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Treatment"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dietary counseling should be provided to ensure adequate intake of iron and avoid dietary risk factors such as excessive milk intake  (<a class="graphic graphic_table graphicRef114486" href="/d/graphic/114486.html" rel="external">table 4</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The diagnosis of iron deficiency is confirmed if there is an appropriate response to empiric iron therapy. (See <a class="local">'Empiric trial of iron therapy'</a> above.)</p><p></p><p class="headingAnchor" id="H1111167433"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Donald H Mahoney, Jr, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123:615.</a></li><li><a class="nounderline abstract_t">Stoltzfus RJ. Iron deficiency: global prevalence and consequences. Food Nutr Bull 2003; 24:S99.</a></li><li class="breakAll">DeBenoist B, McLean E, Egli I, et al. World Health Organization. Worldwide prevalence of anemia 1993-2005: WHO global database on anemia. 2008. Available at: http://www.who.int/vmnis/anaemia/prevalence/en/ (Accessed on July 11, 2017).</li><li class="breakAll">World Health Organization: WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations (2020). Available at: https://www.who.int/publications/i/item/9789240000124 (Accessed on July 27, 2021).</li><li><a class="nounderline abstract_t">Fletcher A, Forbes A, Svenson N, et al. Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children. Br J Haematol 2022; 196:523.</a></li><li><a class="nounderline abstract_t">Abdullah K, Birken CS, Maguire JL, et al. Re-Evaluation of Serum Ferritin Cut-Off Values for the Diagnosis of Iron Deficiency in Children Aged 12-36 Months. J Pediatr 2017; 188:287.</a></li><li><a class="nounderline abstract_t">Mei Z, Addo OY, Jefferds ME, et al. Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study. Lancet Haematol 2021; 8:e572.</a></li><li><a class="nounderline abstract_t">Sayers DR, Witkop CT, Webber BJ. Impact of Altitude-based Hemoglobin Modification on Pediatric Iron Deficiency Anemia Screening. J Pediatr 2020; 221:196.</a></li><li><a class="nounderline abstract_t">Powers JM, Buchanan GR. Potential for Improved Screening, Diagnosis, and Treatment for Iron Deficiency and Iron Deficiency Anemia in Young Children. J Pediatr 2017; 188:8.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Iron deficiency--United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002; 51:897.</a></li><li><a class="nounderline abstract_t">Gupta PM, Hamner HC, Suchdev PS, et al. Iron status of toddlers, nonpregnant females, and pregnant females in the United States. Am J Clin Nutr 2017; 106:1640S.</a></li><li><a class="nounderline abstract_t">Brotanek JM, Gosz J, Weitzman M, Flores G. Secular trends in the prevalence of iron deficiency among US toddlers, 1976-2002. Arch Pediatr Adolesc Med 2008; 162:374.</a></li><li><a class="nounderline abstract_t">Brotanek JM, Halterman JS, Auinger P, et al. Iron deficiency, prolonged bottle-feeding, and racial/ethnic disparities in young children. Arch Pediatr Adolesc Med 2005; 159:1038.</a></li><li><a class="nounderline abstract_t">Cusick SE, Mei Z, Cogswell ME. Continuing anemia prevention strategies are needed throughout early childhood in low-income preschool children. J Pediatr 2007; 150:422.</a></li><li><a class="nounderline abstract_t">Brotanek JM, Gosz J, Weitzman M, Flores G. Iron deficiency in early childhood in the United States: risk factors and racial/ethnic disparities. Pediatrics 2007; 120:568.</a></li><li><a class="nounderline abstract_t">Nead KG, Halterman JS, Kaczorowski JM, et al. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114:104.</a></li><li><a class="nounderline abstract_t">Pinhas-Hamiel O, Newfield RS, Koren I, et al. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27:416.</a></li><li class="breakAll">World Health Organization. Anaemia in children &lt;5 years (2017). Available at: http://apps.who.int/gho/data/view.main.ANEMIACHILDRENREGv?lang=en (Accessed on January 26, 2021).</li><li class="breakAll">World Health Organization. Prevalence of anaemia in women (2017). Available at: https://apps.who.int/gho/data/node.main.ANAEMIAWOMEN?lang=en (Accessed on January 26, 2021).</li><li class="breakAll">Andrews NC, Bridges KR. Disorders of iron metabolism and sideroblastic anemia. In: Hematology of Infancy and Childhood, 5th, Nathan DG, Orkin SH (Eds), WB Saunders, Philadelphia 1998. p.423.</li><li><a class="nounderline abstract_t">Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372:1832.</a></li><li class="breakAll">Ohls, RK. Evaluation and treatment of anemia in the neonate. In: Hematologic Problems of the Neonate, 1st ed, Christensen, RD (Eds), Saunders, 2000. p.137.</li><li><a class="nounderline abstract_t">Kivivuori SM, Virtanen M, Raivio KO, et al. Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants. Eur J Pediatr 1999; 158:147.</a></li><li><a class="nounderline abstract_t">Kumar A, Rai AK, Basu S, et al. Cord blood and breast milk iron status in maternal anemia. Pediatrics 2008; 121:e673.</a></li><li><a class="nounderline abstract_t">Rahimy MC, Fanou L, Somasse YE, et al. When to start supplementary iron to prevent iron deficiency in early childhood in sub-Saharan Africa setting. Pediatr Blood Cancer 2007; 48:544.</a></li><li><a class="nounderline abstract_t">Garcia-Casal MN, Peña-Rosas JP, De-Regil LM, et al. Fortification of maize flour with iron for controlling anaemia and iron deficiency in populations. Cochrane Database Syst Rev 2018; 12:CD010187.</a></li><li><a class="nounderline abstract_t">Suchdev PS, Peña-Rosas JP, De-Regil LM. Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women. Cochrane Database Syst Rev 2015; :CD011158.</a></li><li><a class="nounderline abstract_t">Collard KJ. Iron homeostasis in the neonate. Pediatrics 2009; 123:1208.</a></li><li><a class="nounderline abstract_t">Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010; 126:1040.</a></li><li><a class="nounderline abstract_t">Tunnessen WW Jr, Oski FA. Consequences of starting whole cow milk at 6 months of age. J Pediatr 1987; 111:813.</a></li><li><a class="nounderline abstract_t">Ziegler EE, Fomon SJ, Nelson SE, et al. Cow milk feeding in infancy: further observations on blood loss from the gastrointestinal tract. J Pediatr 1990; 116:11.</a></li><li><a class="nounderline abstract_t">Hopkins D, Emmett P, Steer C, et al. Infant feeding in the second 6 months of life related to iron status: an observational study. Arch Dis Child 2007; 92:850.</a></li><li><a class="nounderline abstract_t">Male C, Persson LA, Freeman V, et al. Prevalence of iron deficiency in 12-mo-old infants from 11 European areas and influence of dietary factors on iron status (Euro-Growth study). Acta Paediatr 2001; 90:492.</a></li><li><a class="nounderline abstract_t">Pizarro F, Yip R, Dallman PR, et al. Iron status with different infant feeding regimens: relevance to screening and prevention of iron deficiency. J Pediatr 1991; 118:687.</a></li><li><a class="nounderline abstract_t">Iron fortification of infant formulas. American Academy of Pediatrics. Committee on Nutrition. Pediatrics 1999; 104:119.</a></li><li><a class="nounderline abstract_t">Abrams SA, Hampton JC, Finn KL. A Substantial Proportion of 6- to 12-Month-Old Infants Have Calculated Daily Absorbed Iron below Recommendations, Especially Those Who Are Breastfed. J Pediatr 2021; 231:36.</a></li><li><a class="nounderline abstract_t">Hallberg L, Brune M, Rossander L. Effect of ascorbic acid on iron absorption from different types of meals. Studies with ascorbic-acid-rich foods and synthetic ascorbic acid given in different amounts with different meals. Hum Nutr Appl Nutr 1986; 40:97.</a></li><li><a class="nounderline abstract_t">Cook JD. Adaptation in iron metabolism. Am J Clin Nutr 1990; 51:301.</a></li><li><a class="nounderline abstract_t">Hallberg L, Hulthén L. Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron. Am J Clin Nutr 2000; 71:1147.</a></li><li><a class="nounderline abstract_t">Disler PB, Lynch SR, Charlton RW, et al. The effect of tea on iron absorption. Gut 1975; 16:193.</a></li><li><a class="nounderline abstract_t">Hallberg L, Rossander L, Skånberg AB. Phytates and the inhibitory effect of bran on iron absorption in man. Am J Clin Nutr 1987; 45:988.</a></li><li><a class="nounderline abstract_t">Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1.</a></li><li><a class="nounderline abstract_t">Agostoni C, Turck D. Is cow's milk harmful to a child's health? J Pediatr Gastroenterol Nutr 2011; 53:594.</a></li><li><a class="nounderline abstract_t">Salstrom JL, Kent M, Liang X, Wang M. Toddlers with anasarca and severe anemia: a lesson in preventive medicine. Curr Opin Pediatr 2012; 24:129.</a></li><li><a class="nounderline abstract_t">Sutcliffe TL, Khambalia A, Westergard S, et al. Iron depletion is associated with daytime bottle-feeding in the second and third years of life. Arch Pediatr Adolesc Med 2006; 160:1114.</a></li><li><a class="nounderline abstract_t">Brotanek JM, Schroer D, Valentyn L, et al. Reasons for prolonged bottle-feeding and iron deficiency among Mexican-American toddlers: an ethnographic study. Acad Pediatr 2009; 9:17.</a></li><li><a class="nounderline abstract_t">Hutchinson C. A review of iron studies in overweight and obese children and adolescents: a double burden in the young? Eur J Nutr 2016; 55:2179.</a></li><li><a class="nounderline abstract_t">Sanad M, Osman M, Gharib A. Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr 2011; 37:34.</a></li><li><a class="nounderline abstract_t">Yanoff LB, Menzie CM, Denkinger B, et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007; 31:1412.</a></li><li><a class="nounderline abstract_t">del Giudice EM, Santoro N, Amato A, et al. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009; 94:5102.</a></li><li><a class="nounderline abstract_t">de Vizia B, Poggi V, Conenna R, et al. Iron absorption and iron deficiency in infants and children with gastrointestinal diseases. J Pediatr Gastroenterol Nutr 1992; 14:21.</a></li><li class="breakAll">American Academy of Pediatrics Committee on Nutrition. Iron. In: Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2019. p.561.</li><li class="breakAll">American Academy of Pediatrics Committee on Nutrition. Nutritional needs of the preterm infant. In: Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2019. p.113.</li><li><a class="nounderline abstract_t">McMillan JA, Oski FA, Lourie G, et al. Iron absorption from human milk, simulated human milk, and proprietary formulas. Pediatrics 1977; 60:896.</a></li><li class="breakAll">World Health Organization: Guideline - Daily iron supplementation in infants and children (2016). Available at: http://apps.who.int/iris/bitstream/handle/10665/204712/9789241549523_eng.pdf;jsessionid=4CBF01758D45E7FA69736CC617A515C2?sequence=1 (Accessed on June 10, 2021).</li><li class="breakAll">World Health Organization: Guideline - Intermittent iron supplementation in preschool and school-aged children (2011). Available at: http://apps.who.int/iris/bitstream/handle/10665/44648/9789241502009_eng.pdf?sequence=1 (Accessed on June 10, 2021).</li><li><a class="nounderline abstract_t">Suchdev PS, Jefferds MED, Ota E, et al. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database Syst Rev 2020; 2:CD008959.</a></li><li><a class="nounderline abstract_t">Csölle I, Felső R, Szabó É, et al. Health outcomes associated with micronutrient-fortified complementary foods in infants and young children aged 6-23 months: a systematic review and meta-analysis. Lancet Child Adolesc Health 2022; 6:533.</a></li><li><a class="nounderline abstract_t">Muriuki JM, Mentzer AJ, Mitchell R, et al. Malaria is a cause of iron deficiency in African children. Nat Med 2021; 27:653.</a></li><li><a class="nounderline abstract_t">McDonagh MS, Blazina I, Dana T, et al. Screening and routine supplementation for iron deficiency anemia: a systematic review. Pediatrics 2015; 135:723.</a></li><li><a class="nounderline abstract_t">American Academy of Pediatrics Committee on Nutrition: The use of whole cow's milk in infancy. Pediatrics 1992; 89:1105.</a></li><li><a class="nounderline abstract_t">Lozoff B, Castillo M, Clark KM, Smith JB. Iron-fortified vs low-iron infant formula: developmental outcome at 10 years. Arch Pediatr Adolesc Med 2012; 166:208.</a></li><li><a class="nounderline abstract_t">Gahagan S, Delker E, Blanco E, et al. Randomized Controlled Trial of Iron-Fortified versus Low-Iron Infant Formula: Developmental Outcomes at 16 Years. J Pediatr 2019; 212:124.</a></li><li><a class="nounderline abstract_t">Engelmann MD, Davidsson L, Sandström B, et al. The influence of meat on nonheme iron absorption in infants. Pediatr Res 1998; 43:768.</a></li><li><a class="nounderline abstract_t">Fitch CW, Cannon MS, Seidel GE, Krummel DA. Dietary factors affecting iron status of children residing in rural West Virginia. W V Med J 2008; 104:19.</a></li><li class="breakAll">National Institutes of Health, Office of Dietary Supplements. Dietary supplement fact sheet: Iron. Available at: http://ods.od.nih.gov/factsheets/iron.asp (Accessed on September 23, 2010).</li><li><a class="nounderline abstract_t">Yadav D, Chandra J. Iron deficiency: beyond anemia. Indian J Pediatr 2011; 78:65.</a></li><li><a class="nounderline abstract_t">Brown WD, Dyment PG. Pagophagia and iron deficiency anemia in adolescent girls. Pediatrics 1972; 49:766.</a></li><li><a class="nounderline abstract_t">Osman YM, Wali YA, Osman OM. Craving for ice and iron-deficiency anemia: a case series from Oman. Pediatr Hematol Oncol 2005; 22:127.</a></li><li><a class="nounderline abstract_t">Haoui R, Gautie L, Puisset F. [Pica: a descriptive study of patients in a speciality medical center]. Encephale 2003; 29:415.</a></li><li><a class="nounderline abstract_t">Sherriff A, Emond A, Bell JC, et al. Should infants be screened for anaemia? A prospective study investigating the relation between haemoglobin at 8, 12, and 18 months and development at 18 months. Arch Dis Child 2001; 84:480.</a></li><li><a class="nounderline abstract_t">Halterman JS, Kaczorowski JM, Aligne CA, et al. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 2001; 107:1381.</a></li><li><a class="nounderline abstract_t">Carter RC, Jacobson JL, Burden MJ, et al. Iron deficiency anemia and cognitive function in infancy. Pediatrics 2010; 126:e427.</a></li><li><a class="nounderline abstract_t">Lozoff B, Clark KM, Jing Y, et al. Dose-response relationships between iron deficiency with or without anemia and infant social-emotional behavior. J Pediatr 2008; 152:696.</a></li><li><a class="nounderline abstract_t">Choudhury V, Amin SB, Agarwal A, et al. Latent iron deficiency at birth influences auditory neural maturation in late preterm and term infants. Am J Clin Nutr 2015; 102:1030.</a></li><li><a class="nounderline abstract_t">Algarín C, Peirano P, Garrido M, et al. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res 2003; 53:217.</a></li><li><a class="nounderline abstract_t">Amin SB, Orlando M, Wang H. Latent iron deficiency in utero is associated with abnormal auditory neural myelination in ≥ 35 weeks gestational age infants. J Pediatr 2013; 163:1267.</a></li><li><a class="nounderline abstract_t">Parkin PC, Koroshegyi C, Mamak E, et al. Association between Serum Ferritin and Cognitive Function in Early Childhood. J Pediatr 2020; 217:189.</a></li><li><a class="nounderline abstract_t">Gingoyon A, Borkhoff CM, Koroshegyi C, et al. Chronic Iron Deficiency and Cognitive Function in Early Childhood. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Lozoff B, Wolf AW, Jimenez E. Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J Pediatr 1996; 129:382.</a></li><li><a class="nounderline abstract_t">Walter T, De Andraca I, Chadud P, Perales CG. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics 1989; 84:7.</a></li><li><a class="nounderline abstract_t">Low M, Farrell A, Biggs BA, Pasricha SR. Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials. CMAJ 2013; 185:E791.</a></li><li><a class="nounderline abstract_t">Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med 2006; 160:1108.</a></li><li><a class="nounderline abstract_t">Lukowski AF, Koss M, Burden MJ, et al. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutr Neurosci 2010; 13:54.</a></li><li><a class="nounderline abstract_t">Congdon EL, Westerlund A, Algarin CR, et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr 2012; 160:1027.</a></li><li><a class="nounderline abstract_t">Lozoff B, Smith JB, Kaciroti N, et al. Functional significance of early-life iron deficiency: outcomes at 25 years. J Pediatr 2013; 163:1260.</a></li><li><a class="nounderline abstract_t">Pasricha SR, Hasan MI, Braat S, et al. Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh. N Engl J Med 2021; 385:982.</a></li><li><a class="nounderline abstract_t">Pasricha SR, Hayes E, Kalumba K, Biggs BA. Effect of daily iron supplementation on health in children aged 4-23 months: a systematic review and meta-analysis of randomised controlled trials. Lancet Glob Health 2013; 1:e77.</a></li><li><a class="nounderline abstract_t">De-Regil LM, Jefferds ME, Sylvetsky AC, Dowswell T. Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database Syst Rev 2011; :CD009085.</a></li><li><a class="nounderline abstract_t">Zehetner AA, Orr N, Buckmaster A, et al. Iron supplementation for breath-holding attacks in children. Cochrane Database Syst Rev 2010; :CD008132.</a></li><li><a class="nounderline abstract_t">Dosman C, Witmans M, Zwaigenbaum L. Iron's role in paediatric restless legs syndrome - a review. Paediatr Child Health 2012; 17:193.</a></li><li><a class="nounderline abstract_t">Dye TJ, Jain SV, Simakajornboon N. Outcomes of long-term iron supplementation in pediatric restless legs syndrome/periodic limb movement disorder (RLS/PLMD). Sleep Med 2017; 32:213.</a></li><li><a class="nounderline abstract_t">Hartfield DS, Tan J, Yager JY, et al. The association between iron deficiency and febrile seizures in childhood. Clin Pediatr (Phila) 2009; 48:420.</a></li><li><a class="nounderline abstract_t">Köksal AO, Özdemir O, Büyükkaragöz B, et al. The Association Between Plasma Ferritin Level and Simple Febrile Seizures in Children. J Pediatr Hematol Oncol 2016; 38:512.</a></li><li><a class="nounderline abstract_t">Kumari PL, Nair MK, Nair SM, et al. Iron deficiency as a risk factor for simple febrile seizures--a case control study. Indian Pediatr 2012; 49:17.</a></li><li><a class="nounderline abstract_t">Papageorgiou V, Vargiami E, Kontopoulos E, et al. Association between iron deficiency and febrile seizures. Eur J Paediatr Neurol 2015; 19:591.</a></li><li><a class="nounderline abstract_t">Zareifar S, Hosseinzadeh HR, Cohan N. Association between iron status and febrile seizures in children. Seizure 2012; 21:603.</a></li><li><a class="nounderline abstract_t">Thibault H, Galan P, Selz F, et al. The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity. Eur J Pediatr 1993; 152:120.</a></li><li><a class="nounderline abstract_t">Galan P, Thibault H, Preziosi P, Hercberg S. Interleukin 2 production in iron-deficient children. Biol Trace Elem Res 1992; 32:421.</a></li><li><a class="nounderline abstract_t">Ekiz C, Agaoglu L, Karakas Z, et al. The effect of iron deficiency anemia on the function of the immune system. Hematol J 2005; 5:579.</a></li><li><a class="nounderline abstract_t">Baltimore RS, Shedd DG, Pearson HA. Effect of iron saturation on the bacteriostasis of human serum: in vivo does not correlate with in vitro saturation. J Pediatr 1982; 101:519.</a></li><li><a class="nounderline abstract_t">Kumar V, Choudhry VP. Iron deficiency and infection. Indian J Pediatr 2010; 77:789.</a></li><li><a class="nounderline abstract_t">Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br Med J 1978; 2:1113.</a></li><li><a class="nounderline abstract_t">Zlotkin S, Newton S, Aimone AM, et al. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA 2013; 310:938.</a></li><li><a class="nounderline abstract_t">Neuberger A, Okebe J, Yahav D, Paul M. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev 2016; 2:CD006589.</a></li><li><a class="nounderline abstract_t">Gera T, Sachdev HP. Effect of iron supplementation on incidence of infectious illness in children: systematic review. BMJ 2002; 325:1142.</a></li><li><a class="nounderline abstract_t">Stoffel NU, Uyoga MA, Mutuku FM, et al. Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants. Front Immunol 2020; 11:1313.</a></li><li><a class="nounderline abstract_t">Benedict SL, Bonkowsky JL, Thompson JA, et al. Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia. J Child Neurol 2004; 19:526.</a></li><li><a class="nounderline abstract_t">Maguire JL, deVeber G, Parkin PC. Association between iron-deficiency anemia and stroke in young children. Pediatrics 2007; 120:1053.</a></li><li><a class="nounderline abstract_t">Cohen CT, Agrusa JE, Hui SR, et al. A preventable death: Fatal stroke due to severe iron deficiency anemia. Pediatr Blood Cancer 2023; 70:e30014.</a></li><li><a class="nounderline abstract_t">Siu AL, US Preventive Services Task Force. Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement. Pediatrics 2015; 136:746.</a></li><li class="breakAll">The UK NSC recommendation on Iron Deficiency Anaemia screening in children under 5 years of age. Available at: http://www.screening.nhs.uk/irondeficiency (Accessed on April 08, 2015).</li><li class="breakAll">Abdullah K, Zlotkin S, et al. Canadian Paediatric Surveillance Program: Iron deficiency anemia in children, 2011. Available at: http://www.cpsp.cps.ca/uploads/publications/RA-iron-deficiency-anemia.pdf.</li><li><a class="nounderline abstract_t">Boutry M, Needlman R. Use of diet history in the screening of iron deficiency. Pediatrics 1996; 98:1138.</a></li><li><a class="nounderline abstract_t">White KC. Anemia is a poor predictor of iron deficiency among toddlers in the United States: for heme the bell tolls. Pediatrics 2005; 115:315.</a></li><li><a class="nounderline abstract_t">Wright RO, Shannon MW, Wright RJ, Hu H. Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health 1999; 89:1049.</a></li><li><a class="nounderline abstract_t">Wright RO, Tsaih SW, Schwartz J, et al. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. J Pediatr 2003; 142:9.</a></li><li><a class="nounderline abstract_t">Oski FA. Iron deficiency in infancy and childhood. N Engl J Med 1993; 329:190.</a></li><li><a class="nounderline abstract_t">Sazawal S, Dhingra U, Dhingra P, et al. Efficiency of red cell distribution width in identification of children aged 1-3 years with iron deficiency anemia against traditional hematological markers. BMC Pediatr 2014; 14:8.</a></li><li><a class="nounderline abstract_t">Cusick SE, Looker AC, Cogswell ME, et al. Iron-status indicators. Pediatrics 2008; 121:651.</a></li><li><a class="nounderline abstract_t">Brugnara C, Zurakowski D, DiCanzio J, et al. Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999; 281:2225.</a></li><li><a class="nounderline abstract_t">Ullrich C, Wu A, Armsby C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005; 294:924.</a></li><li><a class="nounderline abstract_t">Wians FH Jr, Urban JE, Keffer JH, Kroft SH. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. Am J Clin Pathol 2001; 115:112.</a></li><li><a class="nounderline abstract_t">Sandoval C, Jayabose S, Eden AN. Trends in diagnosis and management of iron deficiency during infancy and early childhood. Hematol Oncol Clin North Am 2004; 18:1423.</a></li><li><a class="nounderline abstract_t">De Caterina M, Grimaldi E, Di Pascale G, et al. The soluble transferrin receptor (sTfR)-ferritin index is a potential predictor of celiac disease in children with refractory iron deficiency anemia. Clin Chem Lab Med 2005; 43:38.</a></li><li><a class="nounderline abstract_t">Kurekci AE, Atay AA, Sarici SU, et al. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia? J Trop Pediatr 2005; 51:166.</a></li><li><a class="nounderline abstract_t">Powers JM, Buchanan GR, Adix L, et al. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial. JAMA 2017; 317:2297.</a></li></ol></div><div id="topicVersionRevision">Topic 5925 Version 74.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24297872" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A systematic analysis of global anemia burden from 1990 to 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17016951" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Iron deficiency: global prevalence and consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17016951" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Iron deficiency: global prevalence and consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17016951" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Iron deficiency: global prevalence and consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34693519" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28431746" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Re-Evaluation of Serum Ferritin Cut-Off Values for the Diagnosis of Iron Deficiency in Children Aged 12-36 Months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34329578" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32446480" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Impact of Altitude-based Hemoglobin Modification on Pediatric Iron Deficiency Anemia Screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28549635" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Potential for Improved Screening, Diagnosis, and Treatment for Iron Deficiency and Iron Deficiency Anemia in Young Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12418542" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Iron deficiency--United States, 1999-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29070559" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Iron status of toddlers, nonpregnant females, and pregnant females in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18391147" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Secular trends in the prevalence of iron deficiency among US toddlers, 1976-2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16275794" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Iron deficiency, prolonged bottle-feeding, and racial/ethnic disparities in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17382124" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Continuing anemia prevention strategies are needed throughout early childhood in low-income preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17766530" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Iron deficiency in early childhood in the United States: risk factors and racial/ethnic disparities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15231915" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Overweight children and adolescents: a risk group for iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629572" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Greater prevalence of iron deficiency in overweight and obese children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629572" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Greater prevalence of iron deficiency in overweight and obese children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629572" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Greater prevalence of iron deficiency in overweight and obese children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12629572" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Greater prevalence of iron deficiency in overweight and obese children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25946282" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Iron-deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25946282" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Iron-deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10048613" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310187" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cord blood and breast milk iron status in maternal anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17226841" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : When to start supplementary iron to prevent iron deficiency in early childhood in sub-Saharan Africa setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30577080" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fortification of maize flour with iron for controlling anaemia and iron deficiency in populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26091836" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19336381" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Iron homeostasis in the neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20923825" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3681544" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Consequences of starting whole cow milk at 6 months of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2295949" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cow milk feeding in infancy: further observations on blood loss from the gastrointestinal tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17537759" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Infant feeding in the second 6 months of life related to iron status: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11430706" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prevalence of iron deficiency in 12-mo-old infants from 11 European areas and influence of dietary factors on iron status (Euro-Growth study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2019922" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Iron status with different infant feeding regimens: relevance to screening and prevention of iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10390274" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Iron fortification of infant formulas. American Academy of Pediatrics. Committee on Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33144115" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A Substantial Proportion of 6- to 12-Month-Old Infants Have Calculated Daily Absorbed Iron below Recommendations, Especially Those Who Are Breastfed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3700141" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effect of ascorbic acid on iron absorption from different types of meals. Studies with ascorbic-acid-rich foods and synthetic ascorbic acid given in different amounts with different meals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2407101" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Adaptation in iron metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10799377" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prediction of dietary iron absorption: an algorithm for calculating absorption and bioavailability of dietary iron.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1168162" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The effect of tea on iron absorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3034044" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Phytates and the inhibitory effect of bran on iron absorption in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9563847" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21921812" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Is cow's milk harmful to a child's health?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22157360" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Toddlers with anasarca and severe anemia: a lesson in preventive medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17088513" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Iron depletion is associated with daytime bottle-feeding in the second and third years of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19329087" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Reasons for prolonged bottle-feeding and iron deficiency among Mexican-American toddlers: an ethnographic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26883916" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A review of iron studies in overweight and obese children and adolescents: a double burden in the young?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21771327" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17438557" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Inflammation and iron deficiency in the hypoferremia of obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19850683" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1573507" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Iron absorption and iron deficiency in infants and children with gastrointestinal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1573507" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Iron absorption and iron deficiency in infants and children with gastrointestinal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1573507" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Iron absorption and iron deficiency in infants and children with gastrointestinal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/564020" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Iron absorption from human milk, simulated human milk, and proprietary formulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/564020" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Iron absorption from human milk, simulated human milk, and proprietary formulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/564020" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Iron absorption from human milk, simulated human milk, and proprietary formulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32107773" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35753314" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Health outcomes associated with micronutrient-fortified complementary foods in infants and young children aged 6-23 months: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33619371" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Malaria is a cause of iron deficiency in African children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25825534" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Screening and routine supplementation for iron deficiency anemia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1594357" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : American Academy of Pediatrics Committee on Nutrition: The use of whole cow's milk in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064877" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Iron-fortified vs low-iron infant formula: developmental outcome at 10 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31253407" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Randomized Controlled Trial of Iron-Fortified versus Low-Iron Infant Formula: Developmental Outcomes at 16 Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9621986" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The influence of meat on nonheme iron absorption in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18557494" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Dietary factors affecting iron status of children residing in rural West Virginia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18557494" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Dietary factors affecting iron status of children residing in rural West Virginia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20814842" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Iron deficiency: beyond anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4504176" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pagophagia and iron deficiency anemia in adolescent girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15804997" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Craving for ice and iron-deficiency anemia: a case series from Oman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14615690" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : [Pica: a descriptive study of patients in a speciality medical center].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11369562" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Should infants be screened for anaemia? A prospective study investigating the relation between haemoglobin at 8, 12, and 18 months and development at 18 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11389261" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20660551" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Iron deficiency anemia and cognitive function in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18410777" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Dose-response relationships between iron deficiency with or without anemia and infant social-emotional behavior.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26310540" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Latent iron deficiency at birth influences auditory neural maturation in late preterm and term infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12538778" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23932211" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Latent iron deficiency in utero is associated with abnormal auditory neural myelination in≥35 weeks gestational age infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31685227" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Association between Serum Ferritin and Cognitive Function in Early Childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36412051" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Chronic Iron Deficiency and Cognitive Function in Early Childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8804327" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Iron-deficiency anemia and infant development: effects of extended oral iron therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2472596" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Iron deficiency anemia: adverse effects on infant psychomotor development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24130243" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17088512" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20406573" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22244466" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23827739" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Functional significance of early-life iron deficiency: outcomes at 25 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34496174" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Benefits and Risks of Iron Interventions in Infants in Rural Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25104162" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effect of daily iron supplementation on health in children aged 4-23 months: a systematic review and meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22161444" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Intermittent iron supplementation for improving nutrition and development in children under 12 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20464763" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Iron supplementation for breath-holding attacks in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23543250" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Iron's role in paediatric restless legs syndrome - a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27282843" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Outcomes of long-term iron supplementation in pediatric restless legs syndrome/periodic limb movement disorder (RLS/PLMD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19229063" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The association between iron deficiency and febrile seizures in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27467370" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The Association Between Plasma Ferritin Level and Simple Febrile Seizures in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21719928" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Iron deficiency as a risk factor for simple febrile seizures--a case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26112262" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Association between iron deficiency and febrile seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22796045" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Association between iron status and febrile seizures in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8444218" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : The immune response in iron-deficient young children: effect of iron supplementation on cell-mediated immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1375084" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Interleukin 2 production in iron-deficient children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692603" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The effect of iron deficiency anemia on the function of the immune system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6750065" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Effect of iron saturation on the bacteriostasis of human serum: in vivo does not correlate with in vitro saturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20589461" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Iron deficiency and infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/361162" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : The adverse effect of iron repletion on the course of certain infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24002280" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26921618" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Oral iron supplements for children in malaria-endemic areas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433763" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Effect of iron supplementation on incidence of infectious illness in children: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32754150" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15526958" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Cerebral sinovenous thrombosis in children: another reason to treat iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17974743" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Association between iron-deficiency anemia and stroke in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36152002" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : A preventable death: Fatal stroke due to severe iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347426" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347426" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347426" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8951266" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Use of diet history in the screening of iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15687438" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Anemia is a poor predictor of iron deficiency among toddlers in the United States: for heme the bell tolls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10394314" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Association between iron deficiency and low-level lead poisoning in an urban primary care clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12520247" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8515791" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Iron deficiency in infancy and childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24428927" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Efficiency of red cell distribution width in identification of children aged 1-3 years with iron deficiency anemia against traditional hematological markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310220" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Iron-status indicators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10376576" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Reticulocyte hemoglobin content to diagnose iron deficiency in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16118382" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Screening healthy infants for iron deficiency using reticulocyte hemoglobin content.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11190796" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15511623" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Trends in diagnosis and management of iron deficiency during infancy and early childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15653440" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The soluble transferrin receptor (sTfR)-ferritin index is a potential predictor of celiac disease in children with refractory iron deficiency anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15855306" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28609534" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
